6,531 followers
New research: RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report: Patients with metastatic pancreatic cancer have limited treatment options and a dismal prognosis. While RET fusion is rare (0.6%)… https://t.c